{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:43:44Z","timestamp":1785775424342,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ctim.2022.102866","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T11:43:52Z","timestamp":1659527032000},"page":"102866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: A randomized double-blind active-controlled trial"],"prefix":"10.1016","volume":"70","author":[{"given":"Muhammad Amjad","family":"Pervez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilshad Ahmed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakeel Ahmed","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atiq Ur Rehman","family":"Slehria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Aamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ctim.2022.102866_bib1","article-title":"The role of vitamins in non-alcoholic fatty liver disease: a systematic review","volume":"13","author":"Abe","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ctim.2022.102866_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jfma.2020.07.006","article-title":"Non-alcoholic fatty liver disease: a review with clinical and pathological correlation","volume":"120","author":"Chen","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1016\/j.ctim.2022.102866_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ctim.2022.102866_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"10.1016\/j.ctim.2022.102866_bib5","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/01.TP.0000140499.23683.0D","article-title":"Noninvasive evaluation of graft steatosis in living donor liver transplantation","volume":"78","author":"Iwasaki","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.ctim.2022.102866_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ctim.2022.102866_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/nu12010259","article-title":"Potential role of tocotrienols on non-communicable diseases: a review of current evidence","volume":"12","author":"Wong","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ctim.2022.102866_bib8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fphar.2017.00444","article-title":"Vitamin E as a potential interventional treatment for metabolic syndrome: evidence from animal and human studies","volume":"8","author":"Wong","year":"2017","journal-title":"Front Pharm"},{"issue":"1","key":"10.1016\/j.ctim.2022.102866_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1475-2891-12-166","article-title":"Tocotrienols for normalisation of hepatic echogenic response in non-alcoholic fatty liver: a randomised placebo-controlled clinical trial","volume":"12","author":"Magosso","year":"2013","journal-title":"Nutr J"},{"key":"10.1016\/j.ctim.2022.102866_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102494","article-title":"Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with non-alcoholic fatty liver disease: a randomized, placebo-controlled trial","volume":"52","author":"Pervez","year":"2020","journal-title":"Complement Ther Med"},{"issue":"3","key":"10.1016\/j.ctim.2022.102866_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/nu11030677","article-title":"Impact of nutritional changes on non-alcoholic fatty liver disease","volume":"11","author":"Perdomo","year":"2019","journal-title":"Nutrients"},{"issue":"27","key":"10.1016\/j.ctim.2022.102866_bib12","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4254\/wjh.v7.i27.2749","article-title":"Vitamin E reduces liver stiffness in non-alcoholic fatty liver disease","volume":"7","author":"Fukui","year":"2015","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.ctim.2022.102866_bib13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.ctim.2022.102866_bib14","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"issue":"10","key":"10.1016\/j.ctim.2022.102866_bib15","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc17-0518","article-title":"Comparison of ipragliflozin and pioglitazone effects on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, 24-week, open-label, active-controlled trial","volume":"40","author":"Ito","year":"2017","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ctim.2022.102866_bib16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/10715762.2012.755262","article-title":"Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E","volume":"47","author":"D'Adamo","year":"2013","journal-title":"Free Radic Res"},{"issue":"7","key":"10.1016\/j.ctim.2022.102866_bib17","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1002\/ptr.7113","article-title":"Effects of delta-tocotrienol supplementation on glycemic control, oxidative stress, inflammatory biomarkers, and miRNA expression in type 2 diabetes mellitus: a randomized control trial","volume":"35","author":"Mahjabeen","year":"2021","journal-title":"Phytother Res"},{"issue":"1","key":"10.1016\/j.ctim.2022.102866_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00394-015-1064-1","article-title":"Anti\u2011inflammatory \u03b3\u2011 and \u03b4\u2011tocotrienols improve cardiovascular, liver, and metabolic function in diet\u2011induced obese rats","volume":"56","author":"Wong","year":"2017","journal-title":"Eur J Nutr"},{"issue":"3","key":"10.1016\/j.ctim.2022.102866_bib19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ijo.2014.124","article-title":"Gamma-tocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment","volume":"39","author":"Zhao","year":"2015","journal-title":"Int J Obes"},{"issue":"9\u201310","key":"10.1016\/j.ctim.2022.102866_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.lfs.2008.12.014","article-title":"Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway","volume":"84","author":"Kuhad","year":"2009","journal-title":"Life Sci"},{"key":"10.1016\/j.ctim.2022.102866_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2021.111139","article-title":"Dietary alpha- and gamma-tocopherol (1:5 ratio) supplementation attenuates adipose tissue expansion, hepatic steatosis, and expression of inflammatory markers in a high-fat-diet-fed murine model","volume":"85","author":"Juretic","year":"2021","journal-title":"Nutrition"},{"issue":"9","key":"10.1016\/j.ctim.2022.102866_bib22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.5650\/jos.ess21124","article-title":"Effect of \u03b4-tocopherol on mice adipose tissues and mice adipocytes induced inflammation","volume":"70","author":"Kiyose","year":"2021","journal-title":"J Oleo Sci"},{"issue":"5","key":"10.1016\/j.ctim.2022.102866_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/molecules24050923","article-title":"The role of tocotrienol in protecting against metabolic diseases","volume":"24","author":"Pang","year":"2019","journal-title":"Molecules"},{"issue":"18","key":"10.1016\/j.ctim.2022.102866_bib24","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for non-alcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.ctim.2022.102866_bib25","first-page":"3118","article-title":"Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study","volume":"19","author":"Aller","year":"2015","journal-title":"Eur Rev Med Pharm Sci"},{"issue":"6","key":"10.1016\/j.ctim.2022.102866_bib26","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1111\/jdi.13279","article-title":"Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, open-label, three-arm, active control study","volume":"11","author":"Kinoshita","year":"2020","journal-title":"J Diabetes Investig"},{"issue":"5","key":"10.1016\/j.ctim.2022.102866_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/antiox10050634","article-title":"Vitamin E beyond its antioxidant label","volume":"10","author":"Ungurianu","year":"2021","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.ctim.2022.102866_bib28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3109\/09637486.2013.775228","article-title":"Does grape seed oil improve inflammation and insulin resistance in overweight or obese women?","volume":"64","author":"Irandoost","year":"2013","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.ctim.2022.102866_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4236\/ojgas.2014.45030","article-title":"Effect of vitamin E and alpha lipoic acid in non-alcoholic fatty liver disease: a randomized, Placebo-controlled, open-label, prospective clinical trial (VAIN trial)","volume":"4","author":"Basu","year":"2014","journal-title":"Open J Gastroenterol"},{"key":"10.1016\/j.ctim.2022.102866_bib30","doi-asserted-by":"crossref","unstructured":"Marfianti E, Miladiyah I. Effects of 8-Week Vitamin E (\u03b1 tocopherol) Supplementation on Reduced Insulin Resistance in Non-diabetic Obese Subjects. In: Proceedings of the 1st Jenderal Soedirman International Medical Conference in Conjunction with the 5th Annual Scientific Meeting (Temilnas) Consortium of Biomedical Science-JIMC. Purwokerto, Indonesia; 2020, p. 104\u20138. \u3008https:\/\/doi.org\/10.5220\/0010488501040108\u3009.","DOI":"10.5220\/0010488501040108"},{"issue":"8","key":"10.1016\/j.ctim.2022.102866_bib31","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ejcn.2014.296","article-title":"Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials","volume":"69","author":"Saboori","year":"2015","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.ctim.2022.102866_bib32","doi-asserted-by":"crossref","first-page":"17234","DOI":"10.1038\/s41598-020-73741-6","article-title":"The effect of vitamin E supplementation on selected infammatory biomarkers in adults: a systematic review and meta-analysis of randomized clinical trials","volume":"10","author":"Asbaghi","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ctim.2022.102866_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255205","article-title":"Effects of tocotrienols supplementation on markers of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Khor","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ctim.2022.102866_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnesp.2017.07.004","article-title":"Comparing palm oil tocotrienol rich fraction with \u03b1-tocopherol supplementation on oxidative stress in healthy older adults","volume":"21","author":"Goon","year":"2017","journal-title":"Clin Nutr ESPEN"},{"issue":"2","key":"10.1016\/j.ctim.2022.102866_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.livres.2021.03.004","article-title":"Vitamins and non-alcoholic fatty liver disease: a molecular insight","volume":"5","author":"Raza","year":"2021","journal-title":"Liver Res"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229922000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229922000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:18:50Z","timestamp":1760807930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229922000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":35,"alternative-id":["S0965229922000681"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2022.102866","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: A randomized double-blind active-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2022.102866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102866"}}